Form 4: VolitionRx CEO Salvatore Butera Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Salvatore Butera disposed of 5,834 VolitionRx shares to cover tax obligations related to the settlement of restricted stock units, while retaining 276,719 shares.
Summary
- On October 4, 2024, Salvatore Thomas Butera, CEO of Volition Veterinary and an officer of VolitionRx Ltd, disposed of 5,834 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the settlement of 21,333 restricted stock units.
- The shares were retained by VolitionRx for cancellation, and no shares were sold by Butera or VolitionRx.
- The price per share for the transaction was $0.883.
- Following the transaction, Butera directly owns 276,719 shares of VolitionRx common stock.
- Butera also jointly owns 99,350 shares of common stock with his spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine disposal of shares to cover tax obligations and does not indicate a change in the executive's overall confidence in the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is related to tax obligations, which is a common reason for such filings.
Key Dates
| Date | Description |
|---|---|
| 10/04/2024 | Date of transaction where shares were disposed of to cover tax obligations. |
| 10/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.